4//SEC Filing
REGENERON PHARMACEUTICALS INC 4
Accession 0001708138-17-000007
$REGNCIK 0000872589operating
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 4:44 PM ET
Size
11.7 KB
Accession
0001708138-17-000007
Insider Transaction Report
Form 4
Terifay Robert J
SVP Commercial
Transactions
- Exercise/Conversion
Common Stock
2017-06-15$52.03/sh+48,750$2,536,463→ 72,043 total - Sale
Common Stock
2017-06-16$468.19/sh−21,147$9,900,814→ 23,293 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2017-06-15−48,750→ 30,579 totalExercise: $52.03Exp: 2021-12-16→ Common Stock (48,750 underlying) - Tax Payment
Common Stock
2017-06-15$468.69/sh−22,192$10,401,168→ 44,440 total - Tax Payment
Common Stock
2017-06-15$468.69/sh−5,411$2,536,082→ 66,632 total
Holdings
- 1,699(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- [F2]The option became exercisable with respect to all shares underlying the option on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014.
Documents
Issuer
REGENERON PHARMACEUTICALS INC
CIK 0000872589
Entity typeoperating
IncorporatedNY
Related Parties
1- filerCIK 0000872589
Filing Metadata
- Form type
- 4
- Filed
- Jun 18, 8:00 PM ET
- Accepted
- Jun 19, 4:44 PM ET
- Size
- 11.7 KB